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Abstract
Peritoneal adhesions represent an important clinical 
challenge in gastrointestinal surgery. Peritoneal adhe-
sions are a consequence of peritoneal irritation by 
infection or surgical trauma, and may be considered as 
the pathological part of healing following any perito-
neal injury, particularly due to abdominal surgery. The 
EDODQFH EHWZHHQ ?EULQ GHSRVLWLRQ DQG GHJUDGDWLRQ LV
critical in determining normal peritoneal healing or ad-
hesion formation. Postoperative peritoneal adhesions 
are a major cause of morbidity resulting in multiple 
complications, many of which may manifest several 
years after the initial surgical procedure. In addition 
to acute small bowel obstruction, peritoneal adhesions 
may cause pelvic or abdominal pain, and infertility. 
In this paper, the authors reviewed the epidemiology, 
pathogenesis and various prevention strategies of ad-
hesion formation, using Medline and PubMed search. 
Several preventive agents against postoperative peri-
toneal adhesions have been investigated. Their role 
DLPV LQ DFWLYDWLQJ ?EULQRO\VLV KDPSHULQJ FRDJXODWLRQ
GLPLQLVKLQJ WKH LQ?DPPDWRU\ UHVSRQVH LQKLELWLQJ FRO-
lagen synthesis or creating a barrier between adjacent 
wound surfaces. Their results are encouraging but 
most of them are contradictory and achieved mostly 
LQ DQLPDOPRGHO 8QWLO DGGLWLRQDO ?QGLQJV IURP IXWXUH
clinical researches, only a meticulous surgery can be 
recommended to reduce unnecessary morbidity and 
mortality rates from these untoward effects of surgery. 
In the current state of knowledge, pre-clinical or clini-
cal studies are still necessary to evaluate the effective-
ness of the several proposed prevention strategies of 
postoperative peritoneal adhesions.
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INTRODUCTION
Peritoneal adhesions represent an important clinical chal-
lenge in gastrointestinal surgery. Peritoneal adhesions are 
a consequence of  peritoneal irritation by infection or sur-
gical trauma. They are a major cause of  morbidity, result-
ing in multiple complications, many of  which may mani-
fest several years after the initial surgical procedure[1,2]. 
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Development of  peritoneal adhesions has been studied 
H[WHQVLYHO\EXWWRGDWHWKHUHKDVEHHQQRGH?QLWLYHVWUDW-
egy to prevent their formation, as controversies concern-
ing the effectiveness of  available preventive agents still 
exist. In addition, most of  the available clinical literature 
concern gynecological patients; for patients undergoing 
general and/or abdominal surgery, no recommendations 
or guidelines exist[3]. The aim of  this review is to present 
the epidemiology, pathogenesis and various prevention 
strategies of  adhesion formation. We performed a litera-
ture search for this review in Medline and PubMed, using 
the key words: “adhesions”, “intraperitoneal adhesions”, 
“intra-abdominal adhesions”, “adhesion reduction”, 
“adhesion prevention”, “adhesion formation”, “adhe-
sion pathophysiology”. We also reviewed the reference 
lists in all articles retrieved in the search, as well as those 
of  major texts regarding peritoneal adhesion formation. 
Both clinical and experimental studies upon adhesion for-




Peritoneal adhesions are pathological bonds usually be-
tween omentum, loops of  bowel and the abdominal wall. 
7KHVHERQGVPD\EHD WKLQ?OPRI FRQQHFWLYH WLVVXH D
WKLFN?EURXVEULGJH FRQWDLQLQJEORRGYHVVHOV DQGQHUYH
tissue, or a direct contact between two organ surfaces[4]. 
According to their etiology, peritoneal adhesions may 
be classified as congenital or acquired, which can be 
SRVWLQ?DPPDWRU\RUSRVWRSHUDWLYHWKHPRVWIUHTXHQW[5]. 
Among postoperative adhesion formation, three pro-
cesses may be distinguished: adhesion formationDGKHVLRQV
IRUPHGDWRSHUDWLYHVLWHVde novo adhesion formationDGKH-
VLRQVIRUPHGDWQRQRSHUDWLYHVLWHVDQGadhesion reforma-
tion DGKHVLRQV IRUPHG DIWHU WKH O\VLV RI SUHYLRXV DGKH-
VLRQV[6] . Diamond et al[7] have distinguished type 1 and 
type 2 formation of  postoperative peritoneal adhesions. 
Type 1 or de novo adhesion formation concerns adhesions 
formed at sites that did not have previous adhesions, 
LQFOXGLQJ W\SH$ QRSUHYLRXVRSHUDWLYHSURFHGXUH DW
WKH VLWHRI  DGKHVLRQV DQG W\SH% SUHYLRXVRSHUDWLYH
SURFHGXUHVDWWKHVLWHRI DGKHVLRQV7\SHLQYROYHVDG-




Peritoneal adhesions are mostly induced by surgical 
procedures in the peritoneal cavity, and their prevalence 
after major abdominal procedures has been evaluated at 
63%-97%[8,9]. Overall, approximately one-third of  patients 
who underwent open abdominal or pelvic surgery were 
readmitted an average of  two times over the subsequent 
10 years for conditions directly or possibly related to ad-
hesions, or for further surgery that could potentially be 
complicated by adhesions; > 20% of  all such readmis-
sions occurred during the first year after initial surgery, 
and 4.5% of  readmissions were for adhesive small bowel 
REVWUXFWLRQ $6%2[1,10-13]. Colorectal surgery has proved 
to be the most important type of  surgery that may cause 
intra-abdominal adhesions[14]. This surgery has the high-
est total number of  inpatient episodes, inpatient days, 
operating time, theater time, and costs due to peritoneal 
adhesion-related intestinal obstruction[14]. Among open 




complication of  peritoneal adhesions[1,2,8,9]. At Westmin-
VWHU+RVSLWDO /RQGRQ8QLWHG.LQJGRP LQWHVWLQDORE-
struction accounted for 0.9% of  all admissions, 3.3% of  
PDMRUODSDURWRPLHVDQGRI FDVHVRI ODUJHRU6%2
over 24 years[5]. A 1992 British survey has reported an an-
nual total of  12 000-14 400 cases of  adhesive intestinal 
obstruction. Barmparas et al[15] have studied the incidence 
DQG ULVN IDFWRUV IRU$6%2IROORZLQJ ODSDURWRP\7KH
RYHUDOO LQFLGHQFHRI $6%2ZDVDQG WKH ULVNRI 
$6%2ZDVKLJKO\ LQ?XHQFHGE\ WKH W\SHRI SURFHGXUH
with ileal pouch-anal anastomosis being associated with 
WKHKLJKHVW LQFLGHQFHRI 6%2[15]. ,Q LQ WKH8QLWHG
6WDWHV DGPLVVLRQV IRU DGKHVLRO\VLV DFFRXQWHG IRUQHDUO\
950 000 d of  inpatient care[5]. All these studies have dem-
RQVWUDWHGWKDW$6%2LVDVLJQL?FDQWKHDOWKLVVXHERWKLQ
WKHGHYHORSHG DQGGHYHORSLQJZRUOG+RZHYHU$6%2
risk factors, such as the type of  past surgical procedure, 
the site of  adhesions, as well as the timing and recurrence 
rate of  adhesive obstruction, remain unpredictable or 
poorly understood[5]. 
,QDGGLWLRQWR$6%2SHULWRQHDODGKHVLRQVPD\FDXVH
pelvic or abdominal pain, and infertility[1,2,16]. Peritoneal ad-
hesions may also prolong the time needed to gain access 
to the abdominal cavity at subsequent surgery[17,18], and 
may increase the risk of  bowel injury during subsequent 
surgery[19]. Controversy remains on the role of  peritoneal 
adhesions on abdominal pain. Adhesions have been im-
SOLFDWHGDVDVLJQL?FDQWFDXVHRI FKURQLFSHOYLFSDLQDQG
their surgical lysis has been proposed as the therapeutic 
modality of  choice[20,21]. However, chronic pelvic pain 
is one of  most common gynecological complaints and 
yet remains an enigma. A comparison of  chronic pelvic 
pain patients and asymptomatic infertility patients has 
QRWUHYHDOHGDVLJQL?FDQWGLIIHUHQFHLQWKHGHQVLW\RUWKH
location of  adhesions[22]. Thus, it is possible that a com-
mon mechanism for pelvic pain exists and that adhesions 
are only associated features. Bradykinin, histamine and 
other autocoids are able to stimulate pain receptors. For 
Rapkin et al[22] WKHVH?QGLQJVTXHVWLRQWKHUROHRI SHOYLF
adhesions as a cause of  chronic pelvic pain. According to 
other authors, although adhesions are thought to cause 
pain indirectly by restricting organ motion, thus stretch-
ing and pulling smooth muscle of  adjacent viscera or 
the abdominal wall, adhesions themselves are capable of  
JHQHUDWLQJSDLQVWLPXOL6XODLPDQet al[23] have studied the 
GLVWULEXWLRQ ORFDWLRQVL]HDQGW\SHRI QHUYH?EHUVSUHV-
ent in human peritoneal adhesions, associated or not with 
FKURQLFSHOYLFSDLQ7KH\KDYH IRXQG WKDWQHUYH?EHUV
identified histologically, ultrastructurally, and immuno-
histochemically, were present in all examined peritoneal 
adhesions. Furthermore, fibers expressing the sensory 
neuronal markers calcitonin gene-related protein and 
substance P were present in all adhesions irrespective of  
reports of  chronic abdominopelvic pain. That study has 
suggested that these structures may be capable of  con-
ducting pain after appropriate stimulation, and peritoneal 
adhesions are implicated as a cause of  chronic abdomi-
nopelvic pain. In addition, many patients are relieved of  
their symptoms after adhesiolysis[23].
$VFRQVHTXHQFHSHULWRQHDO DGKHVLRQVKDYH D VLJQL?-
FDQWHFRQRPLF LPSDFW7KHLUGLUHFWFRVWV LQ6ZHGHQFDQ
be estimated to be $13 million annually[24]. It has been esti-
PDWHGWKDWLQWKH8QLWHG6WDWHVWKHUHDUHKRVSLWDOL]D-
tions for adhesion-related problems per 100 000 people, 
and the total cost for hospital and surgical expenditure is 
about $1.3 billion[25]. In some European countries, the di-
rect medical costs for adhesion-related problems are more 
than the surgical expenditure for gastric cancer and almost 
as much as for rectal cancer[3,26,27]. Indeed, postoperative 
adhesions have a profound economic impact, including 
the surgical procedure itself, hospitalization, recuperation 
and lost productivity[25]. During 1988, excluding patient 
DQGLQGLUHFWFRVWVKRVSLWDOL]DWLRQLQWKH8QLWHG6WDWHVDF-
counting for 948 727 d of  inpatient care, was responsible 
for an estimated $1179.9 million in expenditure, of  which 
$925 million was associated with hospital costs and $254.9 
million with surgeons’ fees[25]. The study of  Ray et al[28] 
has demonstrated substantial costs associated with surgi-
cal procedures and hospitalization for adhesiolysis. Dur-
ing 1996, the total annual cost of  adhesions management 
exceeded $2 billion, excluding recuperation and lost 
productivity[28]. Hospitalization for adhesiolysis alone cost 
> $700 million. Furthermore, > 300 000 patients are esti-
PDWHGWRXQGHUJRVXUJHU\WRWUHDWDGKHVLRQLQGXFHG6%2
LQ WKH8QLWHG6WDWHV DQQXDOO\[25]. Thus, developing effec-
tive strategies for adhesion prevention may help to reduce 
adhesions management costs and unnecessary morbidity 
and mortality rates.
3RVWRSHUDWLYHSHULWRQHDODGKHVLRQSDWKRSK\VLRORJ\
The first peritoneal adhesions were described at post-
mortem examination of  a patient with peritoneal tuber-
FXORVLV LQ7RH[SODLQWKLV?QGLQJ LWZDVVXJJHVWHG
in 1849 that coagulated lymphatic vessels may turn into 
?EULQRXVDGKHVLRQV[29,30]8QWLOQRZWKHH[DFWSDWKRSK\VL-
ology of  peritoneal adhesions has remained elusive. De-
spite many clinical and experimental studies, peritoneal 
adhesions pathophysiology remains controversial. 
Aside from the normal peritoneal regeneration, the 
process of  postoperative peritoneal adhesion formation 
may be considered as the pathological part of  healing fol-
lowing any peritoneal injury, particularly due to abdominal 
surgery[5,31]. The balance between fibrin deposition and 
degradation is crucial in determining normal peritoneal 
KHDOLQJRUDGKHVLRQIRUPDWLRQ,I ?EULQLVFRPSOHWHO\GH-
graded, normal peritoneal healing may occur. In contrast, 




Peritoneal injury, due to surgery, infection or irritation, 
initiates inflammation with fibrinous exudate and fibrin 
formation[32]. Fibrin results from coagulation cascade ac-
tivation that is activated in the peritoneal cavity, resulting 
in the formation of  thrombin that triggers conversion 
of  fibrinogen into fibrin. However, owing to activation 
RI WKH?EULQRO\WLFV\VWHPDQ\LQWUDDEGRPLQDO?EULQGH-
posits must be lysed. After abdominal surgery, however, 
the equilibrium between coagulation and fibrinolysis is 
GLVWXUEHGLQIDYRURI WKHFRDJXODWLRQV\VWHP7KXV?EULQ
forms deposits are a matrix for ingrowth of  fibrocol-
ODJHQRXVWLVVXH,QGHHG?EUREODVWV LQYDGHWKH?EULQPD-
WUL[ DQG WKHH[WUDFHOOXODUPDWUL[ (&0 LVSURGXFHGDQG
deposited. This ECM can still be completely degraded 
E\ WKHSURHQ]\PHVRI PDWUL[PHWDOORSURWHDVH 003
leading to normal healing. However, if  this process is 
inhibited by tissue inhibitors of  MMPs, peritoneal adhe-
sions may be formed[33]*HQHUDOO\LI ?EULQRO\VLVGRHVQRW
occur within 5-7 d of  the peritoneal injury, the temporary 
fibrin matrix persists and gradually becomes organized 
ZLWKFROODJHQVHFUHWLQJ?EUREODVWV7KLVSURFHVV OHDGV WR
peritoneal adhesion formation[34,35] and growth of  new 
blood vessels mediated by angiogenic factors[13].
Activation of  the fibrinolytic system results in the 
conversion of  plasminogen into plasmin that is highly ef-
IHFWLYHLQWKHGHJUDGDWLRQRI ?EULQLQWR?EULQGHJUDGDWLRQ
SURGXFWV7LVVXHW\SHSODVPLQRJHQ DFWLYDWRU W3$ DQG
XURNLQDVHW\SHSODVPLQRJHQX3$DUHERWKSODVPLQRJHQ
activators. They are expressed in endothelial cells, meso-
thelial cells and macrophages. tPA, a serine protease, is 
the main plasminogen activator and has a high affinity 
IRU?EULQ ,WELQGV WRD VSHFL?F UHFHSWRUZKLFKH[SRVHV
a strong plasminogen-binding site on the surface of  the 
?EULQPROHFXOH7KHUHIRUH LQWKHSUHVHQFHRI ?EULQWKH
activation rate of  plasminogen is strikingly enhanced, 
ZKHUHDVLQWKHDEVHQFHRI ?EULQW3$LVDSRRUDFWLYDWRU
of  plasminogen[36,37]. This results in higher plasminogen 
activation at the sites where it is required, whereas system-
ic activation is prevented. In the peritoneal cavity, tPA is 
responsible for 95% of  plasminogen-activating activity[38]. 
X3$LVHTXDOO\HIIHFWLYHLQWKHGHJUDGDWLRQRI ?EULQ[39], but 
LWVPXFKORZHUDI?QLW\IRU?EULQUHVXOWV LQDVLJQL?FDQWO\
lower plasminogen-activating activity. Besides activation 
of  plasminogen, uPA may play an important role in tissue 
remodeling[40].
Plasminogen activation is hampered by plasminogen-
DFWLYDWLQJ LQKLELWRU 3$, DQG WKURXJKIRUPDWLRQRI 
inactive complexes. The most potent inhibitor of  tPA 
and uPA is the glycoprotein PAI-1. PAI-2 is less effec-
tive in counteracting plasminogen activators. It probably 
plays a role in peritoneal tissue repair[41]. Both PA-1 and 
PAI-2 are produced by endothelial cells, mesothelial cells, 
monocytes, macrophages and fibroblasts. Other plas-
PLQRJHQDFWLYDWRU LQKLELWRUVKDYHEHHQ LGHQWL?HG3$,
DQGSURWHDVHQH[LQ6HYHUDOSURWHDVHLQKLELWRUVVXFKDV
Arung W et al . Postoperative peritoneal adhesions
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SULQFLSOHV? :6+DOVWHG WKH ILUVW VXUJHRQ
who recognized the importance of  these measures[45]. 
Peritoneal damage should be avoided by careful tissue 
handling, meticulous hemostasis, continuous irrigation 
and avoiding unnecessary drying, ineffective use of  for-
eign bodies, and suturing or clamping of  tissue. The use 
of  fine and biocompatible suture materials, atraumatic 
instruments and starch-free gloves is also recommended. 
6WDUFKHGJORYHVDUHDVLJQL?FDQWULVNIDFWRUIRUSRVWRSHUD-
WLYH DGKHVLRQV 6HYHUDO H[SHULPHQWDO VWXGLHVKDYH VKRZQ
that the use of  starch-powdered gloves during laparotomy 
is associated with an increased risk of  extensive post-
operative peritoneal adhesions[46]. Foreign bodies most 
frequently found in postoperative adhesions are: surface 
powders from surgical gloves; lint from packs, drapes, or 
JRZQVZRRG?EHUVIURPGLVSRVDEOHSDSHULWHPVDQGVX-
ture materials. However, recent data have suggested that, 
in the absence of  an additional peritoneal injury, foreign 
bodies are an infrequent cause of  adhesion induction[9,47]. 
Ordonez et al[48] have evaluated the effect of  training on 
postoperative adhesion formation in a rabbit model. The 
training effect was evaluated by duration of  surgery and 
amount of  bleeding. This study has shown that there 
LV D VLJQL?FDQW HIIHFWRI  H[SHULHQFHRQGXUDWLRQRI  VXU-
gery. With experience, duration of  surgery progressively 
decreases, and postoperative adhesions also decrease in 
extent, tenacity, type and total score. According to these 
?QGLQJV VXUJLFDO WUDLQLQJDQG WKH UHVSHFWRI  VRPHEDVLF
SULQFLSOHV?+DOVWHGLDQSULQFLSOHV?DUHLPSRUWDQWIRUDG-
hesion prevention.
6RPH LQWUDRSHUDWLYH WHFKQLTXHV VXFKDVDYRLGLQJXQ-
necessary peritoneal dissection or avoiding closure of  the 
peritoneum, should be applied. Many experimental studies 
have shown that non-closure of  the peritoneum is associ-
ated with decreased peritoneal adhesion formation[49-51]. 
However, some studies have reported no difference[52,53] 
or even decreased peritoneal adhesion[54] with peritoneal 
closure. However, grafting or suturing peritoneal defects 
may increase peritoneal ischemia, devascularization, and 
necrosis, predisposing the site to decreased fibrinolytic 
activity and increased adhesion formation[55].
Furthermore, surgical trauma should be reduced as 
PXFKDVSRVVLEOH7KH VXUJLFDO DSSURDFK RSHQ vs lapa-
URVFRSLF FRXOGSOD\ DQ LPSRUWDQW UROH LQ WKHGHYHORS-
ment of  adhesions. In most abdominal procedures, the 
laparoscopic approach is associated with a significantly 
lower incidence of  postoperative peritoneal adhesions or 
adhesion-related re-admissions. Brokelman et al[56] have 
shown in a prospective trial that there is no difference in 
tPA antigen, tPA-activity, uPA antigen, or PAI-1 antigen 
concentrations in peritoneal biopsies taken at the begin-
ning compared to the end of  the laparoscopic procedure, 
irrespective of  the intra-abdominal pressure or light activ-
ity. In contrast, some studies have reported no difference 
between both surgical approaches. A role for CO2 pneu-
moperitoneum in adhesion formation after laparoscopic 
surgery has been reported[48,57].
During laparoscopic surgery, CO2 pneumoperitoneum 
by itself  has a real impact on abdominal adhesions. It has 
Arung W et al . Postoperative peritoneal adhesions
D2-macroglobulin, D1-antitrypsin and D2-antiplasmin, 
inhibit plasmin directly. However, their roles in peritoneal 
?EULQRO\VLV DUHQRWZHOOGH?QHG[42]. The balance between 
plasminogen activators and plasminogen inhibitors is cru-
cial in determining normal healing or adhesion formation 
)LJXUH7KHUHIRUH3$, LV FRQVLGHUHG WREH DQ LP-
portant factor in the development of  adhesions and high 
PAI concentrations are found in adhesions and peritoneal 
tissue of  patients with extensive adhesions[43,44].
3UHYHQWLRQ
6HYHUDOSUHYHQWLYHDJHQWVDJDLQVWSRVWRSHUDWLYHSHULWRQHDO
adhesions have been investigated. Their roles are in ac-
WLYDWLQJ?EULQRO\VLV KDPSHULQJ FRDJXODWLRQGLPLQLVKLQJ
WKH LQ?DPPDWRU\ UHVSRQVH LQKLELWLQJFROODJHQ V\QWKHVLV
or creating a barrier between adjacent wound surfaces. 
These prevention strategies can be grouped into four cat-
egories: general principles, surgical techniques, mechanical 
barriers, and chemical agents[3].
General principles and surgical techniques: 6RPHEDVLF
principles should be respected during all abdominal surgical 
procedures. These principles are close to the “Halstedian 
Peritoneal injury
,Q?DPPDWLRQ Blood vessel 
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Figure 1  Balance between plasminogen activators and plasminogen in-
hibitors. TIMP: Tissue inhibitors of metalloproteinases; MMP: Matrix metallopro-
tease; ECM: Extracellular matrix; tPA: Tissue-type plasminogen activator; uPA: 
Urokinase-type plasminogen; PAI: Plasminogen-activating inhibitor.
(-)
Adept is a safe and effective adhesion reduction agent in 
laparoscopy.
There are non-absorbable and bio-absorbable films, 






FHOOXORVH 6HSUDILOP®; Genzyme Biosurgery, Cambridge, 
0$8QLWHG6WDWHV DQGSRO\HWK\OHQJO\FRO 6SUD\*HO®; 
&RQIOXHQW6XUJLFDO ,QF:DOWKDP0$8QLWHG6WDWHV
Preclude is non-degradable and requires a second opera-
tion for removal. The most extensively studied bioab-
VRUEDEOH?OPV DUH6HSUD?OPDQG ,QWHUFHHG 6HSUD?OP LV
absorbed within 7 d and excreted from the body within 
28 d[63,64]. Prospective randomized controlled trials have 
VKRZQWKHHI?FDF\RI 6HSUD?OPLQUHGXFLQJWKHLQFLGHQFH
and extent of  postoperative adhesions[65-68]. However, 
6HSUD?OPPD\FDXVHDVLJQL?FDQW LPSDLUPHQWRI DQDVWR-
moses, and should not be applied to anastomosis cases[69]. 
Other experimental studies have demonstrated that cover-
ing lesions of  the parietal peritoneum with microsurgically 
applied autologous peritoneal transplants can completely 
prevent severe peritoneal adhesion formation. However, 
the advantage of  a synthetic barrier is that the material 
does not need to be obtained surgically and can be cut to 
size outside of  the abdomen and then applied without 
sutures[70].
Chemical agents: Chemical agents generally prevent 
WKHRUJDQL]DWLRQRI  WKHSHUVLVWLQJ?EULQE\?EUREODVWLF
proliferation inhibition. Many agents are used to inhibit 
WKLVSUROLIHUDWLRQVXFKDVQRQVWHURLGDODQWLLQ?DPPDWRU\
GUXJV16$,'VFRUWLFRVWHURLGVFDOFLXPFKDQQHOEORFN-
HUVKLVWDPLQH DQWDJRQLVWV DQWLELRWLFV?EULQRO\WLF DJHQWV
anticoagulants, antioxidants, hormones, vitamins, colchi-
cines and selective immunosuppressors[60].
16$,'VUHGXFHSHULWRQHDODGKHVLRQVLQVRPHDQLPDO
models by prostaglandin and thromboxane synthesis inhi-
bition[9]. They decrease vascular permeability, plasmin in-
hibitors, platelet aggregation, and coagulation and also en-
hance macrophage function[9]. Rodgers et al[71] have shown 
that postoperative administration of  anti-inflammatory 
drugs to the site of  injury reduced the formation of  post-
operative adhesions in two animal models. A rat model 
KDVEHHQXVHGWRLQYHVWLJDWHWKHHI?FDF\RI QLPHVXOLGHD
selective cyclooxygenase-2 inhibitor, in the prevention of  
adhesion formation. This study has shown that preopera-
tive intramuscular or postoperative intraperitoneal admin-
istration of  nimesulide to the site of  injury reduced the 
formation of  postoperative adhesion in this rat model[72]. 
*HQHUDOO\VRPHDQWLLQ?DPPDWRU\GUXJVPD\EHHIIHFWLYH
LQSUHYHQWLQJDGKHVLRQVEXWWKHUHLVQRFOLQLFDOVLJQL?FDQW
evidence from any published study to recommend their 
use in humans for this purpose, and several side effects 
still have to be ascertained[73]. 
Corticosteroid therapy reduces vascular permeability 
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been demonstrated that adhesion formation increases 
with the duration of  CO2 pneumoperitoneum and in-
sufflation pressure[48,57]. Indeed, prolonged laparoscopic 
surgery requires long duration and large volume gas insuf-
?DWLRQVZKLFKUDLVHFRQFHUQVDERXWWKHDGYHUVHHIIHFWVRI 
SURORQJHGJDVLQVXI?DWLRQV[58]. The standard CO2 used in 
current laparoscopic practice is cold dry CO2, which is not 
physiological to the normal conditions of  the peritoneal 
cavity[57]. Many studies have shown that short-duration 
laparoscopy, < 3 h, with cold dry CO2 insufflation can 
cause peritoneal alterations and result in numerous detri-
mental outcomes, including postoperative peritoneal ad-
hesion formation[48,58]7KHEHQH?WVRI KHDWHGKXPLGL?HG
CO2LQVXI?DWLRQ? and 95% relative humidity, physi-
RORJLFDO FRQGLWLRQVKDYHEHHQ UHSRUWHG WR LQFOXGH OHVV
hypothermia, less postoperative pains, shortened recovery 
room stay, better convalescence, less tumor spread and 
growth[48,58], and less adhesion formation[35]. Furthermore, 
Molinas et al[59] have demonstrated that CO2 pneumoperi-
toneum increases postoperative peritoneal adhesions in a 
time- and pressure-dependent relationship, and that this 
increase is reduced by the addition of  2%-4% oxygen, 
suggesting peritoneal hypoxia as the driving mechanism. 
,W VXSSRVHV WKDWZKHQ?EULQRO\WLF DFWLYLW\GHFUHDVHV WKH
process of  adhesion formation does not depend anymore 
on the surgical approach, but evolves on its own account.
Mechanical barriers:/LTXLGRUVROLGPHFKDQLFDOEDUULHUV
may prevent postoperative peritoneal adhesion formation 
by keeping peritoneal surfaces separate during the 5-7 d 
required for peritoneal re-epithelialization. They prevent 
FRQWDFWEHWZHHQWKHGDPDJHGVHURVDOVXUIDFHVIRUWKH?UVW
few critical days. An ideal barrier should be biodegrad-
able, safe, non-inflammatory, non-immunogenic, persist 
during the critical re- mesothelialization phase, stay in 
place without sutures or staples, remain active in the pres-
ence of  blood, and be rapidly and easily applied[60,61]. Also, 
it should not interfere with healing, promote infection, 
or cause adhesions. Barriers are currently considered the 
most useful adjuncts that may reduce postoperative peri-
WRQHDO DGKHVLRQ IRUPDWLRQ9DULRXV VROLGRU?XLGEDUULHU
agents have been tested experimentally and in clinical trials.
/LTXLGV VXFKDV FU\VWDOORLGVGH[WUDQK\DOXURQLF DFLG
cross-linked hyaluronic acid and icodextrin have been 
used to prevent adhesion. They separate injured surfaces 
E\?K\GUR?DWDWLRQ?EXWWKHLUHIIHFWLYHQHVVLVFRQWURYHUVLDO
Crystalloids, such as saline and Ringer’s lactate, are used 
in large amounts but they are rapidly absorbed. The most 
commonly used hypertonic solution was 32% dextran 70, 
but it was abandoned because of  serious complications[61]. 
Other liquid barriers that have the advantage of  a longer 
residence time in the abdominal cavity, such as hyaluronic 





clinical studies[61]. Brown et al[62] have demonstrated that 
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and liberation of  cytokines and chemotactic factors and 
has reduced peritoneal adhesion formation in some ani-
mal models[70]. However, corticosteroids have side effects, 
such as immunosuppression and delayed wound heal-
ing[60,74]. .LUGDNet al[75] have investigated the effectiveness 
of  different doses of  methylprednisolone in preventing 
experimentally induced peritoneal adhesions in rats. They 
have found that there was no difference in the effective-
ness of  different methylprednisolone doses, administered 
topically, in preventing peritoneal adhesion formation, 
and furthermore, steroids did not prevent peritoneal ad-
hesion development[75].
In animal models, these hormones may prevent adhe-
VLRQIRUPDWLRQEXWVRPHVWXGLHVKDYHQRWFRQ?UPHGWKLV
effectiveness in humans[74]. Progesterone has been report-
HG WRKDYH DQ DQWLLQ?DPPDWRU\ DVZHOO DV LPPXQRVXS-
pressive effect, and may prevent adhesion formation[73]. 
+RZHYHU&RQ?QR et al[76] have shown that there was no 
VLJQL?FDQWGLIIHUHQFHRYHUDOOLQWKHLQFLGHQFHRI DGKHVLRQ
formation between progesterone-treated and control rab-
ELWV7KH\KDYHUHYHDOHGDEHQH?FLDOHIIHFWRI SURJHVWHU-
one in the reduction of  only minor adhesion formation 
formed after minor peritoneal damage[76]. Furthermore, it 
has been shown that neither estrogen nor gonadotropin-
releasing hormone prevented adhesion formation, but 
there were fewer adhesions formed in estrogen-treated 
than untreated animals[77].
The use of  anticoagulants to prevent the formation 
of  peritoneal adhesions has been enthusiastically reported 
in the literature[78]. Many molecules have been used, such 
as heparin or dicumarol, which prevents adhesion by in-
FUHDVLQJ WKH?EULQRO\VLVGXH WR VHULQHHVWHUDVH DFWLYLW\[79]. 
Heparin is the most widely investigated anticoagulant 
XVHGIRUSUHYHQWLRQRI DGKHVLRQV+RZHYHULWVHI?FDF\LQ
reducing adhesion formation whether administered alone 
or in combination with interceed barrier has not been 
demonstrated in clinical trials[78].
Fibrinolytic agents such as recombinant tPA, when ap-
plied locally, have reduced adhesions in animal models[73]. 
+RZHYHUWKHVH?EULQRO\WLFDJHQWVPD\FDXVHKHPRUUKDJLF
complications[73]7KUHHGLIIHUHQWGUXJV W3$ $FWLO\VH®; 





at various stages, have been studied for their effective-
ness in preventing intraperitoneal adhesion formation in 
rats[80]. All three agents were effective in preventing adhe-
VLRQVZKHQFRPSDUHGWRWKHFRQWUROJURXS1HYHUWKHOHVV
activated drotrecogin alfa seemed the most effective ex-
cept when considering clinical applicability, in which case 
fondaparinux seemed to offer the greatest advantage[80]. 
However, further studies have suggested that all these 
approaches may have only limited success, impeded lack 
RI VDIHW\HI?FDF\DQGPDQ\DGYHUVHHIIHFWVZLWKRXWHOLPL-
nating the problem of  postoperative peritoneal adhesion 
formation[81,82].
6RPHDQWLELRWLFV DUHFRPPRQO\XVHG IRUSURSK\OD[LV
against postoperative infections and adhesion formation. 
/HVVSHULWRQHDOLQIHFWLRQPD\OHDGWROHVVSHULWRQHDODGKH-
VLRQIRUPDWLRQ/LQH]ROLG=\YR[®3?]HU1HZ<RUN1<
8QLWHG6WDWHVKDVEHHQ IRXQG WR UHGXFH LQWUDSHULWRQHDO
adhesion formation in a rat uterine horn model[83]. How-
ever, other studies have shown that intra-abdominal appli-
cation itself  causes adhesion formation[73] 6RUWLQL et al[84] 
have shown that antibiotics led to greater adhesion forma-
tion by Zühlke score as compared to saline, whereas no 
difference was observed between antiseptics and saline. 
Indeed, antibiotics in intraperitoneal irrigation solutions 
have been demonstrated to increase peritoneal adhesion 
formation in rat models, and thus, are not recommended 
as a single agent for adhesion prevention[79].
Vitamin E is the most studied vitamin in adhesion 
prevention. In vitro studies have demonstrated that vitamin 
E has antioxidant, anti-inflammatory, anticoagulant and 
DQWL?EUREODVWLFHIIHFWVDQGGHFUHDVHVFROODJHQSURGXFWLRQ
It has been found to be effective for reducing adhesion 
formation by some authors[85]. Corrales et al[86] have shown 
that vitamin E, administered intraperitoneally, is as effec-
tive as carboxymethylcellulose membrane in preventing 
postoperative adhesions. By contrast, the same effect has 
not been achieved after intramuscular administration[87]. A 
VLJQL?FDQWGLIIHUHQFHKDVEHHQIRXQGEHWZHHQLQWUDSHULWR-
neal and intramuscular vitamin E administration[87]. Thus, 
intraperitoneal administration of  vitamin E might be 
recommended to prevent adhesion formation. However, 
according to our literature review, there have been no hu-
man studies that have recommended the use of  vitamin E 
for postoperative adhesion prevention.
One study has been carried out to elucidate the effects 
of  different concentrations of  methylene blue on the pro-
FHVVRI SHULWRQHDO DGKHVLRQ IRUPDWLRQ DQG WRGH?QH LWV
minimum dose that can effectively prevent the formation 
of  such adhesions in a rat model[88]. It could be concluded 
that 1% methylene blue had the best anti-adhesion poten-
tial[88]. If  methylene blue prevents peritoneal adhesions, it 
FDQFDXVHVLJQL?FDQWLPSDLUPHQWRI DQDVWRPRWLFEXUVWLQJ
pressure during the early phase of  the wound healing pro-
cess by its transient inhibitory effect on the nitric oxide 
pathway[89].
$GKHVLRQVDUHDUHVXOWRI  WKH LQ?DPPDWRU\UHVSRQVH
to tissue injury in the peritoneal space. Although the 
mechanism is unclear, local anesthetics are reported to 
KDYH VRPHDQWLLQ?DPPDWRU\ HIIHFWV DV VKRZQ LQ VRPH
animal studies[90]. These anti-inflammatory effects are 
related to the inhibition of  neutrophils. It has also been 
VKRZQ WKDW ORFDO DQHVWKHWLFV DFWLYDWH WKH?EULQRO\WLF V\V-
tem, reduce factor ?, plasminogen and D2-antiplasmin 
concentration, and inhibit platelet aggregation[91,92]. Thus, 
besides the accelerative effect of  a mixture of  2.5% lido-
caine and 2.5% prilocaine in the wound healing process, 
some studies have demonstrated that intraperitoneal lido-
caine and prilocaine inhibit the formation of  postopera-
tive peritoneal adhesions without compromising wound 
healing in a bacterial peritonitis rat model[93].
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+HSDWRF\WHJURZWKIDFWRU+*)FDQLQKLELWFROODJHQ
deposition and has fibrinolytic capacity[94,95]/LX et al[96] 
have demonstrated that local application of  recombinant 
adenovirus carrying the HGF gene reduced adhesion 
formation in a rat model. Other studies have investigated 
the use of  gene therapy to manage postoperative adhe-
VLRQV6PDGDSURWHLQWKDWRFFXSLHVDVWUDWHJLFSRVLWLRQ
in fibrinogenesis, inhibits transforming growth factor-E
and has the potential to attenuate postoperative adhesion. 
Guo et al[97] have investigated in an experimental model 
WKHWKHUDSHXWLFSRWHQWLDORI H[RJHQRXV6PDGWRSUHYHQW
fibrinogenesis in postoperative intra-abdominal adhe-
sion. In this rat model, ultrasound-microbubble-mediated 
6PDG WUDQVIHFWLRQ VLJQL?FDQWO\GHFUHDVHG WKH LQFLGHQFH
and severity of  peritoneal adhesions, but the use of  tar-
JHWHGJHQH WKHUDS\ DV DSUHYHQWLYH DJHQW DJDLQVW$6%2
still needs extensive evaluation before any clinical trial.
CONCLUSION 
Postoperative peritoneal adhesions are a major health 
SUREOHPZLWKDVLJQL?FDQWHFRQRPLFLPSDFW)LEULQRO\VLV
seems to be a key factor in determining the pathogenesis 
RI DGKHVLRQIRUPDWLRQDQGLQLWVSUHYHQWLRQ6HYHUDOVWXG-
ies on this problem have been conducted. Their results 
are encouraging, but most of  them are contradictory and 
KDYHEHHQ FRQGXFWHG LQ DQLPDOPRGHOV8QWLO DGGLWLRQDO
findings from future clinical studies, only meticulous 
surgery can be recommended to reduce unnecessary mor-
bidity and mortality rates from these untoward effects of  
surgery. In the current state of  knowledge, preclinical or 
clinical studies are still necessary to evaluate the effective-
ness of  the several proposed prevention strategies for 
postoperative peritoneal adhesions. 
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